Found: 19
Select item for more details and to access through your institution.
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00266-y
- By:
- Publication type:
- Article
[<sup>225</sup>Ac]Ac- and [<sup>111</sup>In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00208-0
- By:
- Publication type:
- Article
Dose predictions for [<sup>177</sup>Lu]Lu-DOTA-panitumumab F(ab′)<sub>2</sub> in NRG mice with HNSCC patient-derived tumour xenografts based on [<sup>64</sup>Cu]Cu-DOTA-panitumumab F(ab′)<sub>2</sub> – implications for a PET theranostic strategy
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00140-1
- By:
- Publication type:
- Article
Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, <sup>111</sup>In or β-particle emitting, <sup>177</sup>Lu.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1186/s41181-020-00111-y
- By:
- Publication type:
- Article
Auger electrons for cancer therapy – a review.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41181-019-0075-2
- By:
- Publication type:
- Article
Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with Lu.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 3, p. 579, doi. 10.1007/s11095-016-2082-2
- By:
- Publication type:
- Article
Monte Carlo N-Particle (MCNP) Modeling of the Cellular Dosimetry of <sup>64</sup>Cu: Comparison with MIRDcell S Values and Implications for Studies of Its Cytotoxic Effects.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 2, p. 339, doi. 10.2967/jnumed.116.175695
- By:
- Publication type:
- Article
Intratumorally Injected <sup>177</sup>Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 936, doi. 10.2967/jnumed.115.168906
- By:
- Publication type:
- Article
Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using <sup>177</sup>Lu- or <sup>111</sup>In-Labeled Bispecific Radioimmunoconjugates.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 3, p. 444, doi. 10.2967/jnumed.115.162339
- By:
- Publication type:
- Article
Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation.
- Published in:
- Medical Physics, 2013, v. 40, n. 11, p. 114101, doi. 10.1118/1.4823787
- By:
- Publication type:
- Article
Trastuzumab Labeled to High Specific Activity with In by Conjugation to G4 PAMAM Dendrimers Derivatized with Multiple DTPA Chelators Exhibits Increased Cytotoxic Potency on HER2-Positive Breast Cancer Cells.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 8, p. 1999, doi. 10.1007/s11095-013-1044-1
- By:
- Publication type:
- Article
Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 137, n. 1, p. 81, doi. 10.1007/s10549-012-2338-4
- By:
- Publication type:
- Article
In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 135, n. 1, p. 189, doi. 10.1007/s10549-012-2137-y
- By:
- Publication type:
- Article
Cellular Dosimetry Using the Geant4 Monte Carlo Toolkit.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 9, p. 1489, doi. 10.2967/jnumed.110.079129
- By:
- Publication type:
- Article
Cellular Dosimetry of <sup>111</sup>In Using Monte Carlo N-Particle Computer Code: Comparison with Analytic Methods and Correlation with In Vitro Cytotoxicity.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 462, doi. 10.2967/jnumed.109.063156
- By:
- Publication type:
- Article
Micro-SPECT/CT with <sup>111</sup>In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated HER2 Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 8, p. 1340, doi. 10.2967/jnumed.109.062224
- By:
- Publication type:
- Article
Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to <sup>111</sup>In-DTPA-hEGF.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 8, p. 1353, doi. 10.2967/jnumed.108.051805
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Inhibition Modulates the Nuclear Localization and Cytotoxicity of the Auger Electron--Emitting Radiopharmaceutical <sup>111</sup>In-DTPA--Human Epidermal Growth Factor.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 9, p. 1562, doi. 10.2967/jnumed.107.044073
- By:
- Publication type:
- Article
<sup>111</sup>In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 8, p. 1357, doi. 10.2967/jnumed.106.037937
- By:
- Publication type:
- Article